Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury

The tyrosine kinase inhibitor (TKI) imatinib in rare cases can cause acute toxic hepatitis, hepatic failure, and death. Currently, the choice of further chronic myeloid leukemia (CML) therapy in patients after acute hepatotoxicity is still a difficult question, which requires a complex individual ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopina, Nataliia, Dmytrenko, Iryna, Hamov, Dmytro, Lopin, Dmytro, Dyagil, Iryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559390/
https://www.ncbi.nlm.nih.gov/pubmed/31245199
http://dx.doi.org/10.7759/cureus.4411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559390/
https://www.ncbi.nlm.nih.gov/pubmed/31245199
http://dx.doi.org/10.7759/cureus.4411

Ejemplares similares